News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
He Wei-Wu
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/18/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
SC 13D/A
| He Wei-Wu reports a 17.5% stake in CASI Pharmaceuticals, Inc. |
| 11/19/2021 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 200,000 shares
@ $0.99, valued at
$198k
Bought 200,000 shares
@ $0.98, valued at
$196k
|
|
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/23/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Gifted 380,000 shares
@ $0 |
|
| 11/24/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 127,471 shares
@ $2.12, valued at
$270.2k
Bought 100,000 shares
@ $2.18, valued at
$218k
|
|
| 07/29/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 29,801 shares
@ $2.03, valued at
$60.5k
Bought 56,464 shares
@ $2.37, valued at
$133.8k
|
|
| 05/19/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 100,000 shares
@ $1.82, valued at
$182k
Bought 338,932 shares
@ $2.02, valued at
$684.6k
|
|
| 03/30/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 6,880 shares
@ $2.08, valued at
$14.3k
|
|
| 03/27/2020 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 196,398 shares
@ $1.94, valued at
$381k
Bought 328,095 shares
@ $2.09, valued at
$685.7k
|
|
| 03/24/2020 |
SC 13D/A
| He Wei-Wu reports a 12.1% stake in CASI Pharmaceuticals, Inc. |
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2019 |
4
| He Wei-Wu (Chairman and CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 374,321 warrants
@ $1.69, valued at
$632.6k
|
|
| 08/20/2019 |
4
| He Wei-Wu (CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $3.2, valued at
$64k
|
|
| 08/15/2019 |
4
| He Wei-Wu (CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 160,000 shares
@ $3.17, valued at
$507.2k
|
|
| 06/21/2019 |
4
| He Wei-Wu (CEO) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 4,000,000 options to buy
@ $2.85, valued at
$11.4M
|
|
| 12/21/2018 |
4
| He Wei-Wu (10% Owner) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Gifted 200,000 shares
@ $0 |
|
| 06/12/2018 |
4
| He Wei-Wu (10% Owner) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $3.22, valued at
$3.2M
|
|
| 04/04/2018 |
SC 13D/A
| He Wei-Wu reports a 10.4% stake in CASI Pharmaceuticals, Inc. |
| 03/21/2018 |
4
| He Wei-Wu (10% Owner) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 3,086,419 shares
@ $3.24, valued at
$10M
Granted 1,234,567 warrants
@ $3.69, valued at
$4.6M
|
|
| 01/12/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 10/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|